She is a member of the National Payer’s Evaluation Committee for Specialised Medicines and Companion Diagnostics (CieBAG). This committee decides on the reimbursement of medicines and molecular diagnostics in the Netherlands. She is also a member of the National Horizon Scanning Group for Oncology and Haematology and affiliated with the Department of Oncology, Leiden University Medical Centre.